Antiplatelet (phosphodiesterase inhibitor + adenosine reuptake inhibitor)
Pregnancy: Avoid unless essential — limited data; aspirin alone preferred for antiplatelet indication in pregnancy.
Dipyridamole
Brand names: Persantin, Persantin Retard, Asasantin Retard (with aspirin)
Adult dose
Dose: Secondary prevention of ischaemic stroke / TIA: Persantin Retard (MR) 200 mg BD, usually combined with aspirin 75 mg OD (Asasantin Retard 200/25 BD provides combined dose). Adjunct to oral anticoagulation in prosthetic valve: 300–600 mg/day in 3–4 divided doses.
Route: Oral
Frequency: BD (MR) or TDS–QDS (IR)
Max: 600 mg/day
Take 1 hour before or 2 hours after meals (food reduces absorption). Modified-release form preferred for long-term use.
Clinical pearls
- ESPS-2 and PRoFESS trials: aspirin + dipyridamole MR vs aspirin alone for stroke 2° prevention — aspirin/dipyridamole more effective in ESPS-2 but tied with clopidogrel monotherapy in PRoFESS. NICE TA210 recommends EITHER clopidogrel monotherapy OR aspirin + MR dipyridamole.
- Headache is the leading cause of discontinuation — counsel that it usually improves over 1–2 weeks; consider paracetamol cover for first week.
- MR formulation has markedly fewer headaches than IR — always prescribe Persantin Retard or Asasantin Retard for chronic use.
- IV dipyridamole used in pharmacological cardiac stress testing — reverse with IV aminophylline 50–100 mg if severe symptoms. Inform patients to stop caffeine 24 hours pre-test.
- Caution in coronary artery disease — coronary steal phenomenon can worsen angina; rarely first-line antiplatelet in IHD (aspirin or clopidogrel preferred).
Contraindications
- Hypersensitivity to dipyridamole
- Active bleeding
- Severe coronary artery disease, recent MI (caution — coronary steal)
- Severe aortic stenosis (caution)
- Acute heart failure (caution)
- Phaeochromocytoma (untreated)
Side effects
- Headache (very common — peaks first 1–2 weeks, often abates with continued use; 20% discontinuation rate)
- GI upset: diarrhoea, nausea, dyspepsia
- Flushing, dizziness, hypotension
- Bleeding (additive with antiplatelets/anticoagulants)
- Tachycardia, palpitations
- Coronary steal — exacerbation of angina (especially during IV stress test use)
- Thrombocytopenia (rare)
Interactions
- Adenosine: ↑ adenosine effect markedly — reduce IV adenosine dose by 4× during cardiac stress imaging; explicitly contraindicated for routine adenosine arrhythmia bolus
- Aspirin: synergistic — combination therapy (Asasantin Retard) is the indication itself
- Anticoagulants (warfarin, DOACs): ↑ bleeding risk
- Theophylline / caffeine: antagonise dipyridamole's adenosine effect — can blunt response in cardiac stress imaging
- Cholinesterase inhibitors: antagonise effect
Monitoring
- FBC if bleeding signs
- Headache control 1–2 weeks
- Stroke recurrence at 3 and 12 months
Reference: BNF 90; SmPC Persantin Retard / Asasantin Retard; NICE TA210 (2010); ESPS-2 J Neurol Sci 1996;143:1; PRoFESS NEJM 2008;359:1238; ESO Stroke Guidelines 2022. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DAPT Score · Coronary Artery Disease
- ARC-HBR Criteria for High Bleeding Risk in PCI · Coronary Artery Disease
- PRECISE-DAPT Score for Bleeding on DAPT · Coronary Artery Disease
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- DAPT Decision Tool (Ticagrelor vs Clopidogrel) · Antiplatelet Therapy
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS